![](/img/cover-not-exists.png)
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
Kemmerer, C. L., Pernpeintner, V., Ruschil, C., Abdelhak, A., Scholl, M., Ziemann, U., Krumbholz, M., Hemmer, B., Kowarik, M. C., Richard, YolandeVolume:
15
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0235449
Date:
July, 2020
File:
PDF, 1.69 MB
2020